EyeBio
Principal Scientist - Biomarker Discovery & Translational Neuroscience
EyeBio, Oklahoma City, Oklahoma, United States
Job Description
Location: Boston, MA
Our Company’s Neuroscience is recruiting a Principal Scientist in Boston/Cambridge, MA to develop and oversee implementation of biomarker discovery and translational strategies. We are seeking a highly motivated and experienced scientist to join our Neuroscience team in a role that will drive biomarker discovery and enable clinical translation by integrating cutting‑edge data analytics, novel assay development, and cross‑functional collaboration. The successful candidate will be an experienced neuroscientist with expertise in drug discovery, novel biomarker discovery, and assay development across diverse platforms.
Responsibilities:
Responsibilities
Collaborate with internal and external collaborators to develop and execute comprehensive workplans that interrogate large clinical cohort datasets by applying cutting‑edge scalable biomarker platforms with significant emphasis on OMICs technologies.
Develop and execute biomarker assays within our Company and through external CROs that utilize single or multi‑analyte detection and apply to large clinical cohort serum and CSF sample sets; bridge outcomes to tractable clinical biomarker plans.
Coordinate access to multi‑resolution genetic, transcriptomic, proteomic, and imaging data derived from patient cohorts and tissues, cerebrospinal fluid, serum to decode disease biology that informs on novel targets and discover patient stratification biomarkers in complex diseases of the nervous system.
Co‑lead a cross‑functional team of scientists applying spatial and single‑cell multi‑omics data derived from human, animal model and organoid tissue samples aiming to decode disease‑relevant cellular interactions and cell‑type specific molecular networks with emphasis on neuroimmune mechanisms with the goal of novel biomarker discovery in neurodegenerative diseases (e.g. AD, PD and pain).
Serve as a core member on early clinical development teams and have opportunity to lead project teams.
Clearly communicate results to project teams, our company’s scientific community, and the external scientific community through internal documents, presentations, and publications in leading journals.
Required Experience and Skills
Ph.D. and a minimum of 7 years industry and/or highly relevant applied academic post‑graduate experience or MS and 10+ years of experience.
A solid track record of leading biomarker discovery efforts and working with discovery and early clinical teams.
Experience using translationally‑relevant preclinical models of neurodegenerative diseases.
Demonstrated experience collaborating across bioinformatics, data analytics, and quantitative pharmacometrics teams to decode disease biology through analysis of multi‑modal (transcriptomic, genomic, proteomic) patient‑derived data.
Direct experience developing and validating biomarker assays with emphasis on applying diverse measurement platforms.
Strong ability to work and influence in complex matrixed organizations.
Excellent oral and written communication skills.
Ability to establish and maintain productive cross‑site and external collaborations.
Preferred Experience and Skills
Experience with drug discovery across multiple modalities (e.g., small molecule, biologics, etc.).
Experience as a liaison to academic and large precompetitive consortia focused on the natural history of neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Deep understanding of complex neurodegenerative diseases and/or neurological disorders with knowledge of the latest research and trends in the field. Expertise in general immune and inflammation.
Familiarity with data analytics strategies in the context of traditional and OMICs‑based data sufficient to effectively liaise with data science colleagues applying state‑of‑the‑art AI approaches in neurodegenerative diseases.
Travel Up to 10% travel required.
EEO Statement We provide equal opportunities to all employees and applicants for employment and prohibit discrimination on the basis of race, color, age, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability status, or other applicable legally protected characteristics. As a federal contractor, we comply with all affirmative action requirements for protected veterans and individuals with disabilities.
#J-18808-Ljbffr
Our Company’s Neuroscience is recruiting a Principal Scientist in Boston/Cambridge, MA to develop and oversee implementation of biomarker discovery and translational strategies. We are seeking a highly motivated and experienced scientist to join our Neuroscience team in a role that will drive biomarker discovery and enable clinical translation by integrating cutting‑edge data analytics, novel assay development, and cross‑functional collaboration. The successful candidate will be an experienced neuroscientist with expertise in drug discovery, novel biomarker discovery, and assay development across diverse platforms.
Responsibilities:
Responsibilities
Collaborate with internal and external collaborators to develop and execute comprehensive workplans that interrogate large clinical cohort datasets by applying cutting‑edge scalable biomarker platforms with significant emphasis on OMICs technologies.
Develop and execute biomarker assays within our Company and through external CROs that utilize single or multi‑analyte detection and apply to large clinical cohort serum and CSF sample sets; bridge outcomes to tractable clinical biomarker plans.
Coordinate access to multi‑resolution genetic, transcriptomic, proteomic, and imaging data derived from patient cohorts and tissues, cerebrospinal fluid, serum to decode disease biology that informs on novel targets and discover patient stratification biomarkers in complex diseases of the nervous system.
Co‑lead a cross‑functional team of scientists applying spatial and single‑cell multi‑omics data derived from human, animal model and organoid tissue samples aiming to decode disease‑relevant cellular interactions and cell‑type specific molecular networks with emphasis on neuroimmune mechanisms with the goal of novel biomarker discovery in neurodegenerative diseases (e.g. AD, PD and pain).
Serve as a core member on early clinical development teams and have opportunity to lead project teams.
Clearly communicate results to project teams, our company’s scientific community, and the external scientific community through internal documents, presentations, and publications in leading journals.
Required Experience and Skills
Ph.D. and a minimum of 7 years industry and/or highly relevant applied academic post‑graduate experience or MS and 10+ years of experience.
A solid track record of leading biomarker discovery efforts and working with discovery and early clinical teams.
Experience using translationally‑relevant preclinical models of neurodegenerative diseases.
Demonstrated experience collaborating across bioinformatics, data analytics, and quantitative pharmacometrics teams to decode disease biology through analysis of multi‑modal (transcriptomic, genomic, proteomic) patient‑derived data.
Direct experience developing and validating biomarker assays with emphasis on applying diverse measurement platforms.
Strong ability to work and influence in complex matrixed organizations.
Excellent oral and written communication skills.
Ability to establish and maintain productive cross‑site and external collaborations.
Preferred Experience and Skills
Experience with drug discovery across multiple modalities (e.g., small molecule, biologics, etc.).
Experience as a liaison to academic and large precompetitive consortia focused on the natural history of neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Deep understanding of complex neurodegenerative diseases and/or neurological disorders with knowledge of the latest research and trends in the field. Expertise in general immune and inflammation.
Familiarity with data analytics strategies in the context of traditional and OMICs‑based data sufficient to effectively liaise with data science colleagues applying state‑of‑the‑art AI approaches in neurodegenerative diseases.
Travel Up to 10% travel required.
EEO Statement We provide equal opportunities to all employees and applicants for employment and prohibit discrimination on the basis of race, color, age, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability status, or other applicable legally protected characteristics. As a federal contractor, we comply with all affirmative action requirements for protected veterans and individuals with disabilities.
#J-18808-Ljbffr